Vaxart ( (VXRT)) has issued an update. On June 22, 2026, Vaxart modified its BARDA-funded Project NextGen award to align with the current scope of its Phase 2b comparative trial of an oral COVID-19 ...
Vaxart Inc (NASDAQ:VXRT) shares are trading higher by 17.8% to $0.66 Tuesday morning amid a number of recent news items. The company recently secured a contract from the U.S. Government via the ...
Those who chased its prior rallies may have ended up with losses. But as shares make another retreat, this may be a vaccine play worth rolling the dice on. Emphasis on “rolling the dice.” This company ...
Short interest in Vaxart Inc (NASDAQ:VXRT) increased during the last reporting period, rising from 14.35M to 14.68M. This put 6.51% of the company's publicly available shares short. Short interest in ...
California-based Vaxart (NASDAQ:VXRT) is a biopharmaceutical company that’s known for one relentless business focus: making vaccines. As you would expect, the emergence of Covid-19 last year made VXRT ...
Investors should simply avoid Vaxart (NASDAQ:VXRT) stock at this time. Although VXRT stock has an interesting business model, there is arguably not much behind it. I’ll get to that in a moment, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results